Oxidative stress(OS) and inflammation would be promoters of alterations in metabolic
syndrome(MS). Atorvastatin and Metformin could improve redox state, preventing MS
liver lesions. Bariatric surgery would be effective to treat MS by acting on obesity,
initial condition for developing MS and OS.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Metabolism - Clinical and ExperimentalAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
